"Tumor rejection" refers to the body's natural defense mechanism to recognize and eliminate cancer cells. It means that the immune system recognizes the tumor as a threat and fights against it, preventing the tumor from growing or spreading.
Full definition
Dr. Sharma is a trained medical oncologist and immunologist whose research work is focused on investigating mechanisms and pathways within the immune system that are responsible
for tumor rejection and clinical benefit.
Hotspots of KRAS mutations are found in different tumor types and can serve
as tumor rejection epitopes.
The decreased tumor size and
enhanced tumor rejection in DGKζ - deficient mice indirectly suggests that enhanced Erk signaling may be superior to enhanced NF - κΒ activation in facilitating T cell activity against tumor, especially because DKO mice did not exhibit improved tumor control relative to DGKζ − / − mice.
«Although both anti-CTLA-4 and anti-PD-1
improved tumor rejection, mice treated with anti-CTLA-4 exhibited superior tumor control, suggesting the memory T - cell response by this agent is more durable,» said Allison.
Pramod Srivastava and Lloyd J. Old identify the human homologue of the
mouse tumor rejection antigen gp96.
IDO1 has been implicated in immune modulation through its ability to limit T cell function and engage mechanisms of immune tolerance, and as such
preventing tumor rejection.
This did induce an immune response but only led to
tumor rejection in one - quarter of the animals.»
They normalized blood vessels in the tumor, thus additionally contributing to
tumor rejection.
He proposed that blocking CLTA - 4 could enhance anti-tumor immune responses and conducted the first preclinical experiments showing that CTLA - 4 blockade could lead to
tumor rejection.